Search Results - Emma Dean

  • Showing 1 - 9 results of 9
Refine Results
  1. 1

    The role of general practice nurses in supporting people to quit smoking: A qualitative study. by Hannah Jongebloed, Eileen Cole, Emma Dean, Anna Ugalde

    Published in PLoS ONE (2024-01-01)
    Get full text
    Article


  2. 2

    Hospital staff perspectives on the provision of smoking cessation care: a qualitative description study by Anna Ugalde, Rachel Whiffen, Sarah White, Emma Dean, Lahiru Russell, Lorena Chapman, Jasmine Just

    Published in BMJ Open (2021-05-01)
    Get full text
    Article


  3. 3

    Broadband-NIRS System Identifies Epileptic Focus in a Child with Focal Cortical Dysplasia—A Case Study by Aikaterini Vezyroglou, Peter Hebden, Isabel De Roever, Rachel Thornton, Subhabrata Mitra, Alan Worley, Mariana Alves, Emma Dean, Judith Helen Cross, Ilias Tachtsidis

    Published in Metabolites (2022-03-01)
    Get full text
    Article


  4. 4

    Phase I/II results of ceralasertib as monotherapy or in combination with acalabrutinib in high-risk relapsed/refractory chronic lymphocytic leukemia by Wojciech Jurczak, Nagah Elmusharaf, Christopher P. Fox, William Townsend, Amanda G. Paulovich, Jeffrey R. Whiteaker, Fanny Krantz, Chuan-Chuan Wun, Graeme Parr, Shringi Sharma, Veerendra Munugalavadla, Richa Manwani, Emma Dean, Talha Munir

    Published in Therapeutic Advances in Hematology (2023-05-01)
    Get full text
    Article


  5. 5

    Phase 1b study of berzosertib and cisplatin in patients with advanced triple-negative breast cancer by Melinda L. Telli, Sara M. Tolaney, Geoffrey I. Shapiro, Mark Middleton, Simon R. Lord, Hendrik Tobias Arkenau, Andrew Tutt, Vandana Abramson, Emma Dean, Tufia C. Haddad, Robert Wesolowski, Jordi Ferrer-Playan, Thomas Goddemeier, Thomas Grombacher, Jennifer Dong, Patricia Fleuranceau-Morel, Ivan Diaz-Padilla, Ruth Plummer

    Published in npj Breast Cancer (2022-04-01)
    Get full text
    Article


  6. 6

    Tumor control and immune activation through palliative irradiation and ATR inhibition, PATRIOT Part C: a phase Ib trial by Magnus T. Dillon, Emmanuel C. Patin, Kabir Mohammed, Jeane Guevara, Simon A. Smith, Emma Dean, Heba Soliman, Pablo Nenclares, Motoko Ryugenji, Davina Northcote, Neel Shah, Lorna Grove, Christopher J. Lord, Stephen Pettit, Matt Tall, Karen E. Swales, Udai Banerji, Alan A. Melcher, Mark Saunders, Martin D. Forster, Kevin J. Harrington

    Published in Nature Communications (2025-08-01)
    Get full text
    Article


  7. 7

    Durable responses to ATR inhibition with ceralasertib in tumors with genomic defects and high inflammation by Magnus T. Dillon, Jeane Guevara, Kabir Mohammed, Emmanuel C. Patin, Simon A. Smith, Emma Dean, Gemma N. Jones, Sophie E. Willis, Marcella Petrone, Carlos Silva, Khin Thway, Catey Bunce, Ioannis Roxanis, Pablo Nenclares, Anna Wilkins, Martin McLaughlin, Adoracion Jayme-Laiche, Sarah Benafif, Georgios Nintos, Vineet Kwatra, Lorna Grove, David Mansfield, Paula Proszek, Philip Martin, Luiza Moore, Karen E. Swales, Udai Banerji, Mark P. Saunders, James Spicer, Martin D. Forster, Kevin J. Harrington

    Published in The Journal of Clinical Investigation (2024-01-01)
    Get full text
    Article


  8. 8

    National E-cigarette Monitoring and Evidence Consortium: Supporting informed research, policy and practice in Australia by Emily Banks, Michelle Scollo, Coral Gartner, Becky Freeman, Sinan Brown, Sai Campbell, Amelia Yazidjoglou, Emily Banks, Becky Freeman, Coral Gartner, Michelle Scollo, Renee Bittoun, Alecia Brooks, Gary Chan, Sinan Brown, Louisa Collins, Mike Conway, Emma Dean, Anita Dessaix, Jo Dono, Angela Gazey, Tracey Greenberg, Elizabeth Greenhalgh, Deepali Gupta, Alys Havard, Christina Heris, Laura Hunter, Jonine Jancey, Michelle Jongenelis, Sarah Khanlari, Alexander Larcombe, Carmen Lim, Natalia Lizama, Raglan Maddox, Guy Marks, Kahlia McCausland, James McLennan, Caroline Miller, Kylie Morphett, Megan Passey, Matthew Peters, Simone Pettigrew, Darren Roberts, Robert Roseby, Maree Scully, Abby Smith, Colleen Smyth, Jessamine Soderstrom, Daniel Stjepanović, Matthew Tuson, Moya Vandeleur, Amy Villarosa, Christina Watts, Marianne Weber, Luke Wolfenden, Lisa Wood, Amelia Yazidjoglou, Serene Yoong

    Get full text
    Article


  9. 9

    The ATR inhibitor ceralasertib potentiates cancer checkpoint immunotherapy by regulating the tumor microenvironment by Elizabeth L. Hardaker, Emilio Sanseviero, Ankur Karmokar, Devon Taylor, Marta Milo, Chrysis Michaloglou, Adina Hughes, Mimi Mai, Matthew King, Anisha Solanki, Lukasz Magiera, Ricardo Miragaia, Gozde Kar, Nathan Standifer, Michael Surace, Shaan Gill, Alison Peter, Sara Talbot, Sehmus Tohumeken, Henderson Fryer, Ali Mostafa, Kathy Mulgrew, Carolyn Lam, Scott Hoffmann, Daniel Sutton, Larissa Carnevalli, Fernando J. Calero-Nieto, Gemma N. Jones, Andrew J. Pierce, Zena Wilson, David Campbell, Lynet Nyoni, Carla P. Martins, Tamara Baker, Gilberto Serrano de Almeida, Zainab Ramlaoui, Abdel Bidar, Benjamin Phillips, Joseph Boland, Sonia Iyer, J. Carl Barrett, Arsene-Bienvenu Loembé, Serge Y. Fuchs, Umamaheswar Duvvuri, Pei-Jen Lou, Melonie A. Nance, Carlos Alberto Gomez Roca, Elaine Cadogan, Susan E. Critichlow, Steven Fawell, Mark Cobbold, Emma Dean, Viia Valge-Archer, Alan Lau, Dmitry I. Gabrilovich, Simon T. Barry

    Published in Nature Communications (2024-02-01)
    Get full text
    Article


Search Tools: